Prospective Athlete's Heart Study
- Conditions
- Athlete Heart
- Interventions
- Other: No intervention
- Registration Number
- NCT05164328
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Brief Summary
The Pro@Heart (Prospective Athlete's Heart) study is an international multicentre long-term prospective trial. The primary objective of the Pro@Heart study is to investigate the impact of training load (i.e. accurately evaluated in term of type, frequency, duration and intensity) and genotype on the variability of structural, functional and electrical exercise induced cardiac remodeling (EICR) in young competitive endurance athletes. The second objective is to determine how EICR, training load and genotype are associated with physical performance, health benefits and cardiac pathology (e.g. exercise-related cardiomyopathies and arrhythmias) during follow-up over several decades.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 450
-
Males and females aged 14-23 years old
-
Athletes competing in endurance sports at national or international level for at least 2 years. Sports include:
- Triathlon
- Cycling
- Distance running (≥ 1500 meters)
- Rowing
- Swimming
-
Non athletes engaged in < 3 hours per week of physical activity
- Medical history of cardiovascular disease
- Current smoker of past history of smoking
- Diabetes mellitus
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Athletes No intervention 1. Males and females aged 14-23 years old 2. Athletes competing in endurance sports at national or international level for at least 2 years. Sports include: 1. Triathlon 2. Cycling 3. Distance running (≥ 1500 meters) 4. Rowing 5. Swimming Non-athletes No intervention 1. Males and females aged 14-23 years old 2. Non athletes engaged in \< 3 hours per week of physical activity
- Primary Outcome Measures
Name Time Method Genotype Baseline Rare and common variants in cardiomyopathy associated genes
Atrial fibrillation Baseline to 20 years Ventricular arrhythmias Baseline to 20 years Ventricular ectopic beats, non-sustained and sustained ventricular tachycardia
Training load Baseline to 20 years Duration and intensity of training
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Jessa Ziekenhuis Hasselt
🇧🇪Hasselt, Limburg, Belgium
Baker Heart and Diabetes Institute
🇦🇺Melbourne, Victoria, Australia
UZ Antwerpen
🇧🇪Edegem, Antwerp, Belgium
UZ Leuven
🇧🇪Leuven, Vlaams Brabants, Belgium